Abstracts

Association Between Dideoxynucleoside Analogues (d-drugs) and End-Stage Liver Disease (ESLD)

Background: Whilst some antiretroviral (ARV) drugs, including d-drugs (stavudine [d4T], didanosine [ddI], zalcitabine [ddC]), may cause hepatotoxicity, their association with clinically defined ESLD remains unknown. Whilst rarely used in resource-rich settings, d-drugs are still used in some resource-limited settings. Methodology: D:A:D participants were followed from 1/2/2004 to the earliest of ESLD (variceal bleeding, grade III/IV…

Abacavir and Didanosine Enhance Susceptibility to Acetaminophen-Induced Hepatotoxicity

Background: Liver mitochondrial toxicity induced by nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) is usually associated with disrupted mitochondrial DNA replication. However, mitochondrial dysfunction can also be generated by other mechanisms unrelated to inhibition of Pol-γ. We have analysed the acute effects of clinically relevant concentrations of the most widely used NRTIs on the function of mitochondria…

Cumulative Exposure to Ritonavir-Boosted Atazanavir Is Associated With Cholelithiasis

Background: The effect of long-term treatment with ritonavir-boosted atazanavir (ATV/r) on cholelithiasis formation is unknown. Methodology: A single-center, cross-sectional study was conducted to elucidate the prevalence of cholelithiasis in patients with HIV-1 infection who underwent abdominal ultrasonography between January 2004 and March 2012. Uni- and multi-variate logistic regression analyses were applied to estimate the effects…

HIV-1 Can Be Confirmed by Bio-Rad GeeniusTM HIV 1/2 Confirmatory Assay Using Dried Blood Spots

Background: Confirmatory assays for HIV diagnosis are not well implemented in limited income settings, impeding an early HIV detection and, consequently, delaying the prescription of antiretroviral treatment in the infected population. Bio-Rad GeeniusTM HIV 1/2 Confirmatory Assay is a single-use immunocromatographic test for the confirmation and differentiation of individual antibodies of HIV-1 and HIV-2 in…

Standard Diagnostics Bioline HIV/Syphilis Duo Test: Multi-Site Laboratory Evaluation

Background: The WHO and UNAIDS recommend an integrated strategy for the elimination of congenital syphilis and mother-to-child transmission of HIV. Laboratory-based syphilis diagnostics are complex and implementation can be hampered by logistical difficulties. Recently, test developers have created rapid tests that can detect multiple infections with the same specimen using a single device. The SD…

Comparison of Central and Local HIV-1 RNA Quantification From Two International Clinical Trials

Background: Central measurement of plasma HIV-RNA (pVL) is common in clinical trials. Despite the increased expense and complexity, central testing is believed to reduce variability. In the setting of two international randomised clinical trials we aim to compare trial outcomes on the basis of central and local laboratory assessed pVL. Methodology: Data were available from…

CAP/CTM V. 2.0 Using Dried Blood Spots Ineffective at Diagnosing Antiretroviral Treatment Failure

Background: The 2013 WHO guidelines for antiretroviral treatment (ART) of HIV infections recommend viral load (VL) for routine monitoring and diagnosis of treatment failure (TF) defined as > 1,000 copies/ml. Due to operational simplicity, dried blood spots (DBS) are recommended as an alternative specimen type however at a higher TF diagnostic threshold of 3-5,000 copies/ml.…

Reliable and Accurate CD4 T Cell Count and Percent of the New Portable Flow Cytometer CyFlow MiniPOC

Background: An accurate, reliable, and affordable CD4 T cells count is essential in several parts of the world. Flow cytometry is the “gold standard” for CD4 T cell count, but this technique is expensive and requires sophisticated equipment and trained personnel. In addition, the lack of ready access to technical support and quality assurance programs…

Evaluation of Pima CD4 Point-of-Care Device in Western Kenya for Potential use in Field Settings

Background: Pre-treatment loss to follow-up can be a barrier to effective antiretroviral treatment (ART) programs. CD4 point-of-care (POC) testing may reduce this by improving linkage to care. However, an implementation challenge is accuracy when operated by lay health workers (HIV testing counselors and community health workers) in field settings. We validated the accuracy of Pima’s…